# A Study to Learn About the Study Medicine Called PF-07905428 in Healthy Participants and Participants With Acne Vulgaris

> **NCT06671834** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 52 (actual)

## Conditions studied

- Acne Vulgaris

## Interventions

- **DRUG:** PF-07905428
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06671834
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-11-22
- **Primary completion:** 2025-12-04
- **Final completion:** 2025-12-04
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2025-12-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06671834

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06671834, "A Study to Learn About the Study Medicine Called PF-07905428 in Healthy Participants and Participants With Acne Vulgaris". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT06671834. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*